4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone from cigarette smoke stimulates colon cancer growth via β-adrenoceptors

Cancer Research

Volumn 65, Issue 12, 2005, Pages 5272-5277

  Wu, William K K ^a   Wong, Helen P S ^a   Luo, Shi W ^a   Chan, Kevin ^b   Huang, Fung Y ^a   Hui, Marco K C ^a   Lam, Emily K Y ^a   Shin, Vivian Y ^a   Ye, Yi N ^a   Yang, Ying H ^a   Cho, Chi H ^a,c  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; 4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; ATENOLOL; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; CIGARETTE SMOKE; CYCLIC AMP; CYCLOOXYGENASE 2; ISOPRENALINE; NORADRENALIN; PHOSPHOLIPASE A2; PROSTAGLANDIN E2;

ARTICLE; CANCER GROWTH; CELL PROLIFERATION; COLON CANCER; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ADRENERGIC BETA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; ATENOLOL; CARCINOGENS; CELL GROWTH PROCESSES; COLONIC NEOPLASMS; CYCLIC AMP; CYCLOOXYGENASE 2; DINOPROSTONE; DRUG INTERACTIONS; HT29 CELLS; HUMANS; ISOPROTERENOL; MEMBRANE PROTEINS; NITROSAMINES; NOREPINEPHRINE; PHOSPHOLIPASES A; PROPANOLAMINES; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RECEPTORS, ADRENERGIC, BETA; SMOKE; TOBACCO; UP-REGULATION;

EID: 20444449329     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-05-0205     Document Type: Article

References (34)

1. Vineis P, Alavanja M, Buffler P. et al. Tobacco and cancer: recent epidemiological evidence. J Natl Cancer Inst 2004;96:99-106.
2. Terry MB, Neugut AI, Bostick RM, et al. Risk factors for advanced colorectal adenomas: a pooled analysis. Cancer Epidemiol Biomarkers Prev 2002;11:622-9.
3. Reid ME, Marshall JR, Roe D, et al. Smoking exposure as a risk factor for prevalent and recurrent colorectal adenomas. Cancer Epidemiol Biomarkers Prev 2003;12: 1006-11.
4. Giovannucci E, Rimm EB, Stampfer MJ, et al. A prospective study of cigarette smoking and risk of colorectal adenoma and colorectal cancer in U.S. men. J Natl Cancer Inst 1994;86:183-91.
5. Chao A, Thun MJ, Jacobs EJ, et al. Cigarette smoking and colorectal cancer mortality in the cancer prevention study II. J Natl Cancer Inst 2000;92:1888-96.
6. Colangelo LA, Gapstur SM, Gann PH, Dyer AR. Cigarette smoking and colorectal carcinoma mortality in a cohort with long-term follow-up. Cancer 2004;100: 288-93.
7. CRC CancerStats. London: Cancer Research Campaign: 1999.
8. Wu WK, Cho CH. The pharmacological actions of nicotine on the gastrointestinal tract. J Pharmacol Sci 2004;94:348-58.
9. Adams JD, Lee SJ, Vinchkoski N, Castonguay A, Hoffmann D. On the formation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl) -1-butanone during smoking. Cancer Lett 1983;17:339-46.
10. Hecht SS, Hochalter JB, Villalta PW, Murphy SE. 2′-Hydroxylation of nicotine by cytochrome P450 2A6 and human liver microsomes: formation of a lung carcinogen precursor. Proc Natl Acad Sci U S A 2000;97:12493-7.
11. Schuller HM, Tithof PK, Williams M, Plummer H III. The tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone is a β-adrenergic agonist and stimulates DNA synthesis in lung adenocarcinoma via β-adrenergic receptor-mediated release of arachidonic acid. Cancer Res 1999;59:4510-5.
12. Schuller HM, Cole B. Regulation of cell proliferation by β-adrenergic receptors in a human lung adenocarcinoma cell line. Carcinogenesis 1989;10:1753-5.
13. Weddle DL, Tithoff P, Williams M, Schuller HM. β-Adrenergic growth regulation of human cancer cell lines derived from pancreatic ductal carcinomas. Carcinogenesis 2001;22:473-9.
14. Ye YN, Liu ES, Shin VY, Wu WK, Cho CH. The modulating role of nuclear factor-κB in the action of α7-nicotinic acetylcholine receptor and cross-talk between 5-lipoxygenase and cyclooxygenase-2 in colon cancer growth induced by 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone. J Pharmacol Exp Ther 2004;311: 123-30.
15. Jull BA, Plummer HK III, Schuller HM. Nicotinic receptor-mediated activation by the tobacco-specific nitrosamine NNK of a Raf-1/MAP kinase pathway, resulting in phosphorylation of c-myc in human small cell lung carcinoma cells and pulmonary neuroendocrine cells. J Cancer Res Clin Oncol 2001; 127:707-17.
16. Schultheiss G, Diener M. Adrenoceptor-mediated secretion across the rat colonic epithelium. Eur J Pharmacol 2000;403:251-8.
17. Kennedy MF, Tutton PJ, Barkla DH. Adrenergic factors involved in the control of crypt cell proliferation in jejunum and descending colon of mouse. Clin Exp Pharmacol Physiol 1983;10:577-86.
18. Naro F, Sette C, Vicini E, et al. Involvement of type 4 cAMP-phosphodiesterase in the myogenic differentiation of L6 cells. Mol Biol Cell 1999;10:4355-67.
19. Koehne CH, Dubois RN. COX-2 inhibition and colorectal cancer. Semin Oncol 2004;31:12-21.
20. Ferrandez A, Prescott S, Burt RW. COX-2 and colorectal cancer. Curr Pharm Des 2003;9:2229-51.
21. Mann JR, DuBois RN. Cyclooxygenase-2 and gastrointestinal cancer. Cancer J 2004;10:145-52.
22. Fredriksson JM, Lindquist JM, Bronnikov GE, Nedergaard J. Norepinephrine induces vascular endothelial growth factor gene expression in brown adipocytes through a β-adrenoreceptor/cAMP/protein kinase A pathway involving Src but independently of Erk1/2. J Biol Chem 2000;275:13802-11.
23. Brambilla R, Neary JT, Cattabeni F, et al. Induction of COX-2 and reactive gliosis by P2Y receptors in rat cortical astrocytes is dependent on ERK1/2 but independent of calcium signalling. J Neurochem 2002; 83:1285-96.
24. Luttrell LM, Ferguson SS, Daaka Y, et al. β-Arrestin-dependent formation of β2 adrenergic receptor-Src protein kinase complexes. Science 1999;283:655-61.
25. Cook SJ, Wakelam MJ. Epidermal growth factor increases sn-1,2-diacylglycerol levels and activates phospholipase D-catalysed phosphatidylcholine breakdown in Swiss 3T3 cells in the absence of inositol-lipid hydrolysis. Biochem J 1992;285:247-53.
26. Kim JH, Kim SW, Jung PJ, Yon C, Kim SC, Han JS. Phosphatidylcholine- specific phospholipase C and RhoA are involved in the thyrotropin-induced activation of phospholipase D in FRTL-5 thyroid cells. Mol Cells 2002; 14:272-80.
27. Rice PL, Washington M, Schleman S, Beard KS, Driggers LJ, Ahnen DJ. Sulindac sulfide inhibits epidermal growth factor-induced phosphorylation of extracellular-regulated kinase 1/2 and Bad in human colon cancer cells. Cancer Res 2003;63:616-20.
28. Miele E. The nicotinic stimulation of the cat adrenal medulla Arch Int Pharmacodyn Ther 1969;179:343-51.
29. Narita S, Shibata O, Waki S, Egashira K, Suzuki T. Adrenaline and noradrenaline secretion of the adrenal gland in conscious dogs in response to pilocarpine and nicotine. Tohoku J Exp Med 1973;110:303-5.
30. Masur K, Niggemann B, Zanker KS, Entschladen F. Norepinephrine-induced migration of SW 480 colon carcinoma cells is inhibited by β-blockers. Cancer Res 2001;61:2866-9.
31. Jick H, Jick S, Derby LE, Vasilakis C, Myers MW, Meier CR. Calcium-channel blockers and risk of cancer. Lancet 1997;349:525-8.
32. Pahor M, Guralnik JM, Salive ME, Corti MC, Carbonin P, Havlik RJ. Do calcium channel blockers increase the risk of cancer? Am J Hypertens 1996;9:695-9.
33. Algazi M, Plu-Bureau G, Flahault A, Dondon MG, Le MG. Could treatments with β-blockers be associated with a reduction in cancer risk? Rev Epidemiol Sante Publique 2004;52:53-65.
34. Takezaki T, Hamajima N, Matsuo K, et al. Association of polymorphisms in the β-2 and β-3 adrenoceptor genes with risk of colorectal cancer in Japanese. Int J Clin Oncol 2001;6:117-22.